В регионе более 30% коек в больницах перепрофилировали для лечения пациентов с коронавирусом, сообщают «Витебские вести» со ссылкой на облздрав.
Для оказания медпомощи пациентам с коронавирусной инфекцией в больницах области временно перепрофилировали 3,2 тысячи коек (30,7% всего коечного фонда). В медучреждениях региона задействовано около 20% аппаратов ИВЛ.
Помимо областной инфекционной больницы пациентов с COVID-19 госпитализируют в Витебскую городскую БСМП, горбольницу № 1, областной специализированный центр, нефрологический корпус областной больницы и хирургический корпус онкодиспансера.
На долечивание пациентов направляют в «афганский» центр и областной центр психиатрии и наркологии, реабилитационный центр «Железняки» областного кардиологического центра. Медпомощь женщинам с коронавирусом оказывают в областном роддоме.
Койки для помощи пациентам с пневмониями и коронавирусной инфекцией есть во всех районных больницах.
В облздраве отмечают, что рост случаев инфицирования COVID-19 начался в сентябре. Но по сравнению с первой волной осенний подъем заболеваемости более интенсивный — как среди взрослых, так и среди детей.
По прогнозам Минздрава, выход на плато по заболеваемости коронавирусом ожидается в декабре-январе, а на спад COVID-19, возможно, пойдет весной-летом.
She is partnered with Emmerdale's Joe-Warren Plant on the upcoming series of Dancing On Ice.
And Vanessa Bauer cut a casual figure as she kept up with her exercise regime by going for a run on Sunday.
The professional skater, 24, showcased her toned physique as she donned a black crop top and a matching pair of leggings.
Showcasing her washboard abs, Vanessa also wore a blue jacket on her outing along with black trainers.
Going makeup free for the day, Vanessa completed her look by styling her locks into an updo.
The TV star has been documenting her rehearsals with Joe-Warren on her social media.
It comes hot on the heels of reports that Joe moved out of the home he shared with girlfriend Nicole Hadlow after arguments over his ice skating partner Vanessa.
The actor, 18, is thought to have moved back to his mum's in Blackpool after having rows, with it 'not looking too hopeful' he'll be able to patch things up.
Speaking with The Sun, a friend said: 'Joe and Nicole's relationship has come under strain because of the amount of time he was spending with Vanessa on the ice.
'They've been rowing a lot so decided earlier this month it was best Joe move out. It wasn't what he wanted... but his dedication to the show has put their romance under pressure.'
They added that the actor is hoping to use the Christmas break to work things out with Nicole, however added: 'It’s not looking too hopeful at the moment.'
MailOnline has approached Joe and Vanessa's representatives for a comment.
It comes after insiders alleged lash technician Nicole was not impressed with the time Joe was spending training and deleted snaps of the pair from Instagram.
Last week a source told The Sun: 'Joe and Nicole have had a series of rows in recent weeks...
'Nicole deleted all the recent snaps of them on Instagram recently and has been leaning on her family and friends.'
Joe has been dating Nicole since 2017, while their union was first revealed in 2018, thanks to slew of snaps that Joe posted to Instagram.
The actor, who is best known for his role as Jacob Gallagher in the ITV soap, and Vanessa have been sharing regular updates from their time on the rink.
Sharing an array of videos and snaps from their fun-filled rehearsals last week, Joe revealed they had been given their first routine, which was possibly to the tune of Justin Bieber's Yummy.
The hint came from a slew of the videos shared by both of the dancing duo, with the hit track playing in the back while they zipped around.
In January 2019, Vanessa sparked controversy with her dance partner Wes Nelson, whose then-girlfriend Megan Barton Hanson publically slammed the ice skater for her behaviour with the Love Island hunk.
Rumours of a fling later emerged and Megan and Wes split.
Vanessa remained defiant, as she hit back at the claims, posting on Instagram at the time that rumours of a fling with Wes are 'lies'.
A blood test to detect two molecules that act as indicators of a person's likelihood to get Alzheimer's disease later in life could be a 'game-changer', a new study claims.
The two molecules – P-tau181, a tau protein, and neurofilament light polypeptide (NfL) – are found in plasma, the light yellow liquid that makes up 55 per cent of our blood.
In a sample of 557 people in their 60s and 70s, the presence of high levels of either P-tau181 and NfL were the most accurate predictors of the patient's progression from mild cognitive impairment (MCI) to severe memory and thinking problems, typical of Alzheimer's.
Researchers say blood tests to detect levels of the two molecules could allow doctors to track the progression of Alzheimer's disease progression in at-risk populations.
'Our study is novel in the way we address the individualised predictive value of plasma Alzheimer's disease biomarkers,' say the experts, from Lund University in Sweden.
'Combination of plasma biomarkers may be of high value to identify individuals with MCI who will progress to Alzheimer's in clinical trials and in clinical practice.'
Professor Masud Husain at University of Oxford, who was not involved in the study, called it a 'potential gamechanger'.
'For the first time, we have a blood test that can predict well the risk of subsequent development of Alzheimer's disease in people who have mild cognitive symptoms,' he said.
'We need further validation but in the context of other recent findings this could be a transformative step to earlier diagnosis, as well as testing new treatments at earlier stages of the disease.'
Around 50 million people around the world live with Alzheimer's disease – which accounts for between 50 per cent and 70 per cent of dementia cases.
Although the exact cause of Alzheimer's disease is not yet fully understood, it is thought to be caused by the abnormal build-up of proteins in and around brain cells.
One of the proteins involved is called amyloid, deposits of which form plaques around brain cells.
The other protein is called tau, deposits of which form tangles within brain cells.
Although it's not known exactly what causes this process to begin, scientists now know that it begins many years before symptoms appear.
Led by Oskar Hansson from Lund University, the researchers developed and validated models that could predict an individual's risk of cognitive decline and subsequent transition to Alzheimer's disease.
They used data from 573 patients with minor cognitive impairments from two independent cohorts.
Researchers compared the accuracy of several models based on various combinations of blood biomarkers to predict cognitive decline and dementia over four years.
A decline in brain function was determined by the Mini–Mental State Examination (MMSE) – a 30-point test that consists of a series of questions and tests a number of different mental abilities, including a person's memory, attention and language.
They found the top predictors to be P-tau181, a type of tau protein already known to be a hallmark of Alzheimer's disease, and NfL known to be a marker of neuro-axonal damage.
Combined, they were almost 90 per cent accurate in identifying those who went on to develop the disease.
The findings demonstrate the value of using specific combinations of blood-based biomarkers to make predictions for specific individuals with MCI.
'Like dementia, MCI is an umbrella term describing several symptoms, and can be caused by a number of different underlying diseases,' said Dr Sara Imarisio at Alzheimer’s Research UK.
'We know that over 50 per cent of people with MCI will go on to develop dementia, and it is important that we try to identify those who will and those who will not progress to be able to offer appropriate treatment and advice.'
However, other scientists who were not involved with the study believe further research with larger cohorts is needed.
'This study only looked at a few hundred people, but if these blood biomarkers can predict Alzheimer's in larger, more diverse groups, we could see a revolution in how we test new dementia drugs,' said Dr Richard Oakley, head of research at Alzheimer's Society.
'Blood tests to predict dementia are moving at a break-neck speed, but if government doesn't double dementia research funding as they promised, people with dementia won't benefit from these new breakthroughs.'
Professor Tara Spires-Jones, a neurodegeneration expert at the University of Edinburgh, pointed out that some of the people a high predicted probability of disease based on these proteins in their blood did not go on to develop Alzheimer's.
Likewise, some people with a low predicted probability did go on to develop the disease.
The study is an important step on the road to developing a blood test for Alzheimer's, but it is important to note that we are not there yet,' said Professor Spires-Jones.
'As the authors correctly note, more studies in larger populations and standardised ways of running and interpreting these tests will be needed to confirm their usefulness.'
The study has been published in Nature Aging.
В интервью телеканалу Футбол в Instagram 32-летний защитник турецкого клуба Ризеспор признался, что сейчас они не вместе.
«Сейчас у нас родительские отношения, поскольку у нас есть сын. Не более, не верьте слухам», — добавил Морозюк.
По его словам, у его с женой нормальное адекватное общение, основанное на взаимоуважении, и поскольку у них есть сын, им незачем воевать.
«Будем ли вместе в будущем — не могу сказать. Жизнь такая, что я не могу говорить, что будет со мной через 10 или пять лет», — резюмировал Морозюк.